Literature DB >> 5662583

The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies.

P G Frost, P J Lachmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5662583      PMCID： PMC1578906     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  7 in total

1.  Nucleases and their inhibitors in the cellular components of human blood.

Authors:  S GUPTA; R M HERRIOTT
Journal:  Arch Biochem Biophys       Date:  1963-04       Impact factor: 4.013

2.  Activation of the neutral deoxyribonuclease.

Authors:  R N FEINSTEI
Journal:  J Biol Chem       Date:  1960-03       Impact factor: 5.157

3.  The intravenous injection of bovine crystalline pancreatic desoxyribonuclease into patients.

Authors:  A J JOHNSON; P R GOGER; W S TILLETT
Journal:  J Clin Invest       Date:  1954-12       Impact factor: 14.808

4.  An activator of deoxyribonuclease in rat plasma.

Authors:  R N FEINSTEIN; F O GREEN
Journal:  Arch Biochem Biophys       Date:  1956-02       Impact factor: 4.013

5.  A specific inhibitor for human desoxyribonuclease and an inhibitor of the lupus erythematosus cell phenomenon from leucocytes.

Authors:  N B KURNICK; L I SCHWARTZ; S PARISER; S L LEE
Journal:  J Clin Invest       Date:  1953-03       Impact factor: 14.808

6.  The viscosimetric determination of desoxyribonuclease inhibition.

Authors:  H H HENSTELL; R I FREEDMAN
Journal:  Cancer Res       Date:  1952-05       Impact factor: 12.701

7.  The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro).

Authors:  J H HUMPHREY; R JAQUES
Journal:  J Physiol       Date:  1955-04-28       Impact factor: 5.182
  7 in total
  22 in total

1.  [The LE cell phenomenon. New aspects in molecular biology and immunocytology].

Authors:  R Bauer; R Schütz
Journal:  Arch Dermatol Res       Date:  1979-10       Impact factor: 3.017

2.  The relation of deoxyribonuclease inhibitor levels to the occurrence of antinuclear antibodies in NZB-NZW mice.

Authors:  K Hadjiyannaki; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

3.  Antibodies to nucleoprotein and to hydrazide-altered soluble nucleoprotein in tuberculous patients receiving isoniazid.

Authors:  D Alarcón-Segovia; E Fishbein; V M Betancourt
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

4.  Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA.

Authors:  W Emlen; M Mannik
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

Review 5.  Philip Ellman lecture. Immunological aspects of systemic diseases of the lungs.

Authors:  M Turner-Warwick
Journal:  Proc R Soc Med       Date:  1974-06

6.  Purification of a nuclease from human serum.

Authors:  E J Zöllner; G Seibert; H Slor; R K Zahn
Journal:  Experientia       Date:  1981-06

7.  Degradation of circulating DNA by extracorporeal circulation over nuclease immobilized on nylon microcapsules.

Authors:  D S Terman; A Tavel; T Tavel; D Petty; R Harbeck; G Buffaloe; R Carr
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

8.  Experimental renal disease induced by DNA-anti-DNA immune complexes.

Authors:  P G Natali; E M Tan
Journal:  J Clin Invest       Date:  1972-02       Impact factor: 14.808

9.  A radial diffusion assay for plasma and serum deoxyribonuclease I.

Authors:  S Chitrabamrung; J S Bannett; R L Rubin; E M Tan
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

10.  Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus.

Authors:  S Chitrabamrung; R L Rubin; E M Tan
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.